CH366545A - Verfahren zur Herstellung neuer N-Acyl-sulfonamide - Google Patents
Verfahren zur Herstellung neuer N-Acyl-sulfonamideInfo
- Publication number
- CH366545A CH366545A CH5704858A CH5704858A CH366545A CH 366545 A CH366545 A CH 366545A CH 5704858 A CH5704858 A CH 5704858A CH 5704858 A CH5704858 A CH 5704858A CH 366545 A CH366545 A CH 366545A
- Authority
- CH
- Switzerland
- Prior art keywords
- sub
- amino
- reaction
- phenyl
- acyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 11
- 229940124530 sulfonamide Drugs 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 8
- -1 p-Amino-benzenesulfonyl Chemical group 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- MTERSQYMYBGZTP-UHFFFAOYSA-N 4-amino-n-(5-methyl-2-phenylpyrazol-3-yl)benzenesulfonamide Chemical compound C=1C=CC=CC=1N1N=C(C)C=C1NS(=O)(=O)C1=CC=C(N)C=C1 MTERSQYMYBGZTP-UHFFFAOYSA-N 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- 150000003456 sulfonamides Chemical class 0.000 claims description 4
- 150000008065 acid anhydrides Chemical class 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims description 2
- 239000012345 acetylating agent Substances 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 230000005494 condensation Effects 0.000 claims 1
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- GRDXCFKBQWDAJH-UHFFFAOYSA-N 4-acetamidobenzenesulfonyl chloride Chemical compound CC(=O)NC1=CC=C(S(Cl)(=O)=O)C=C1 GRDXCFKBQWDAJH-UHFFFAOYSA-N 0.000 description 1
- FMKMKBLHMONXJM-UHFFFAOYSA-N 5-methyl-2-phenylpyrazol-3-amine Chemical compound N1=C(C)C=C(N)N1C1=CC=CC=C1 FMKMKBLHMONXJM-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010048960 Streptococcal sepsis Diseases 0.000 description 1
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000003855 acyl compounds Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 150000003938 benzyl alcohols Chemical class 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/42—Benzene-sulfonamido pyrazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH5704858A CH366545A (de) | 1958-03-14 | 1958-03-14 | Verfahren zur Herstellung neuer N-Acyl-sulfonamide |
ES0247571A ES247571A1 (es) | 1958-03-14 | 1959-02-26 | Procedimiento para la obtenciën de nuevas sulfonaminas |
SE2217/59A SE301476B (es) | 1958-03-14 | 1959-03-07 | |
FR835238A FR115M (fr) | 1958-03-14 | 1960-08-08 | Nouveau sulfonamide utilisable en thérapeutique. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH5704858A CH366545A (de) | 1958-03-14 | 1958-03-14 | Verfahren zur Herstellung neuer N-Acyl-sulfonamide |
Publications (1)
Publication Number | Publication Date |
---|---|
CH366545A true CH366545A (de) | 1963-01-15 |
Family
ID=4520879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH5704858A CH366545A (de) | 1958-03-14 | 1958-03-14 | Verfahren zur Herstellung neuer N-Acyl-sulfonamide |
Country Status (4)
Country | Link |
---|---|
CH (1) | CH366545A (es) |
ES (1) | ES247571A1 (es) |
FR (1) | FR115M (es) |
SE (1) | SE301476B (es) |
-
1958
- 1958-03-14 CH CH5704858A patent/CH366545A/de unknown
-
1959
- 1959-02-26 ES ES0247571A patent/ES247571A1/es not_active Expired
- 1959-03-07 SE SE2217/59A patent/SE301476B/xx unknown
-
1960
- 1960-08-08 FR FR835238A patent/FR115M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR115M (fr) | 1960-01-09 |
SE301476B (es) | 1968-06-10 |
ES247571A1 (es) | 1960-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH366545A (de) | Verfahren zur Herstellung neuer N-Acyl-sulfonamide | |
DE1545666C3 (de) | 1- eckige Klammer auf 5-Nitrothiazolyl-(2) eckige Klammer zu -2oxo-hexahydropyrimidin | |
DE834102C (de) | Verfahren zur Herstellung neuer Tropasaeureabkoemmlinge | |
DE863056C (de) | Verfahren zur Herstellung von Kondensationsprodukten | |
AT209337B (de) | Verfahren zur Herstellung der neuen, in 4-Stellung unsubstituierten N-(p-Aminobenzolsulfonyl)-N-acyl-5-amino-1-phenyl-3-methyl-pyrazole | |
AT204033B (de) | Verfahren zur Herstellung des neuen 3-(p-Amino-benzolsulfonamido)-2-phenyl-pyrazols | |
CH366049A (de) | Verfahren zur Herstellung neuer Sulfonamide | |
DE650706C (de) | Verfahren zur UEberfuehrung von Carbonsaeuren in ihre naechsthoeheren Homologen bzw.deren Derivate | |
DE1171561B (de) | Mittel zur Bekaempfung von Mikroorganismen | |
AT222271B (de) | Verfahren zur Herstellung von neuen, therapeutisch wirksamen Sulfonamid-Komplexverbindungen | |
DE882702C (de) | Verfahren zur Herstellung von Imidazolderivaten | |
DE2537294A1 (de) | S-inosylcystein und verfahren zu seiner herstellung | |
DE1670327C3 (de) | Verfahren zur Herstellung von 1eckige Klammer auf 5-Nitrothiazolyl-(2) eckige Klammer zu -2-oxo-tetrahydroimidazolen | |
AT234698B (de) | Verfahren zur Herstellung von 4-Sulfanilamido-2,6-di-nieder-alkoxy-pyrimidinen | |
AT227881B (de) | Verfahren zur Herstellung von neuen Penicillinderivaten | |
CH367182A (de) | Verfahren zur Herstellung von 3-(p-Amino-benzolsulfonamido)-6-oxy-pyridazin | |
DE1620495C (de) | Verfahren zur Herstellung des iso mernfreien Bis (4 hydroxyphenyl) (chinolyl 2) methans und seiner Salze mit Sauren | |
DE1140940B (de) | Verfahren zur Herstellung des N-(p-Aminobenzolsulfonyl)-N-acetyl-5-amino-3-methyl-1-phenyl-pyrazols | |
CH346547A (de) | Verfahren zur Herstellung eines neuen Aminobenzolsulfonamids | |
AT236368B (de) | Verfahren zur Herstellung des neuen 2-Phenyl-3-(p-amino-benzolsulfonamido)-5-äthyl-pyrazols, seiner N4-Formaldehydkondensationsprodukte, sowie den Salzen und N1-Acylderivaten dieser Verbindungen | |
DE820735C (de) | Verfahren zur Herstellung von Harnstoffderivaten | |
AT213899B (de) | Verfahren zur Herstellung des neuen 3-(p-Amino-benzolsulfonamido)-6-oxy-pyridazins und seiner Salze | |
DE935667C (de) | Verfahren zur Herstellung von Phenanthridiniumsalzen | |
AT257057B (de) | Verfahren zur Herstellung von Bis-[4-hydroxymethyl-5-hydroxy-6-methyl-pyridyl-(3)-methyl]-disulfid | |
DE936334C (de) | Verfahren zur Herstellung als Arzneimittel verwendbarer Aldehydderivate |